Level C· Early human research exploring benefitsProspective StudyPubMed

The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.

Veum VL., Dankel SN., Gjerde J., Nielsen HJ., Solsvik MH., Haugen C.

Prospective Study on Systemic / IV, published in Int J Obes (Lond) (2011) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Int J Obes (Lond) (2011)
Country
England
Reported sample size
—
Source database
PubMed
PMID
22143616
DOI
10.1038/ijo.2011.240
Citations
53

Abstract (original English)

Background Adipose tissue is critical for systemic metabolic health. Identifying key factors regulating adipose tissue function is a research priority. The NR4A subfamily of nuclear receptors (NRs) (NR4A1/NUR77, NR4A2/NURR1 and NR4A3/NOR1) has emerged as important proteins in different disease states and in the regulation of metabolic tissues, particularly in liver and muscle. However, the expression of the NR4A members in human adipose tissue has not previously been described, and their target genes are largely unknown. Objective To determine whether the NR4As are differentially expressed in human adipose tissue in obesity, and identify potential NR4A target genes. Design Prospective analysis of s.c. adipose tissue before and 1 year after fat loss, and during in vitro differentiation of primary human preadipocytes. Case-control comparison of omental (OM) adipose tissue. Subjects A total of 13 extremely obese patients undergoing biliopancreatic diversion with duodenal switch for fat loss, 12 extremely obese patients undergoing laparoscopic sleeve gastrectomy and 37 lean individuals undergoing hernia repair or laparotomy were included in the study. Measurements were done by quantitative PCR gene expression analysis of the NR4A members and in silico promoter analysis based on microarray data. Results There was a strong upregulation of the NR4As in extreme obesity and normalizatio

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AdipocytesAdipose TissueAdultDNA-Binding ProteinsDown-RegulationFemaleFollow-Up StudiesGene Expression RegulationHumansMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research